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Abstract
Background: Zambia continues to grapple with a high tuberculosis (TB) burden despite a long running Directly
Observed Treatment Short course programme. Understanding issues that affect patient adherence to treatment
programme is an important component in implementation of a successful TB control programme. We set out to
investigate pulmonary TB patient’s attitudes to seek health care, assess the care received from government health
care centres based on TB patients’ reports, and to seek associations with patient adherence to TB treatment
programme.
Methods: This was a cross-sectional study of 105 respondents who had been registered as pulmonary TB patients
(new and retreatment cases) in Ndola District between January 2006 and July 2007. We administered a structured
questionnaire, bearing questions to obtain individual data on socio-demographics, health seeking behaviour,
knowledge on TB, reported adherence to TB treatment, and health centre care received during treatment to
consenting respondents.
Results: We identified that respondents delayed to seek treatment (68%) even when knowledge of TB symptoms
was high (78%) or when they suspected that they had TB (73%). Respondent adherence to taking medication was
high (77%) but low adherence to submitting follow-up sputum (47%) was observed in this group. Similarly,
caregivers educate their patients more often on the treatment of the disease (98%) and drug taking (100%), than
on submitting sputum during treatment (53%) and its importance (54%). Respondent adherence to treatment was
significantly associated with respondent’s knowledge about the disease and its treatment (p < 0.0001), and with
caregiver’s adherence to treatment guidelines (p = 0.0027).
Conclusions: There is a need to emphasise the importance of submitting follow-up sputum during patient
education and counselling in order to enhance patient adherence and ultimately treatment outcome.
Background
Tuberculosis (TB) continues to be a major health pro-
blem in Zambia, despite a long running National Tuber-
culosis and Leprosy Programme (NTLP). In 2007, the
World Health Organization (WHO) estimated the TB
burden in Zambia to be at 60,337 cases (all forms of
TB) [1]. The TB control efforts have been hampered by
the high level of human immunodeficiency virus (HIV)
infection, especially in urban settings where prevalence
is estimated to be 19.7% [2]. As a result the number of
TB and HIV cases threatens to overwhelm the capacity
of the general health systems. HIV-TB co-infection rates
in Zambia have been estimated at 70% [1].
Zambia adopted the WHO recommended Directly
Observed Treatment Short course (DOTS) strategy as
its primary approach in TB control in 1993 and has offi-
cially reported 100% DOTS coverage in all nine pro-
vinces since 2003 [3]. A good functioning primary
health care system is crucial in the implementation of
DOTS. In Zambia, the NTLP activities have been
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decentralisation of TB treatment services has provided
for more responsibility at the lower levels of the health
care system and in the face of an overwhelming TB
case-load, this move has proved to be beneficial to the
practical implementation of the programme. Despite the
human resource challenges, the use of treatment sup-
porters and community volunteers in the implementa-
tion of DOTS has contributed to the improvement in
cure rates over the past decade from 67% in 2000 to the
global target of 85% by 2006 [3]. The goal of the Zam-
bian NTLP is to prevent and control TB through the
provision of quality diagnostic and treatment services
for TB and TB/HIV- infected individuals at all levels of
the health care delivery system [4].
Assessing access to quality of healthcare service deliv-
ery is complex and multidimensional and will depend
on several aspects that are both patient/community-
related and/or health systems/service related. Several
questions could be considered in this vein, for example,
are patients seeking help when they are sick, and when
they do seek healthcare, are they getting the appropriate
care they require when they need it and ultimately, is
this care effective when they get it? Understanding the
factors that affect or influence care actions in different
settings, will ultimately result in an improvement in
healthcare delivery.
Although there are several reports about health
seeking behaviour of TB patients and factors related to
their delay in seeking health care, compliance to treat-
ment and the role of these factors in treatment out-
come, only a few studies describe patient experience
in accessing TB care throughout treatment. This study
describes and assesses the care received by pulmonary
TB patients from government health care centres, and
the association with patient adherence to TB treat-
ment based on previous TB patients’ reports. The
study also alludes to patient’s attitude to seek health
care for TB.
Methods
Study design and population
This was a cross-sectional study of subjects who had
been treated for pulmonary TB through the NTLP at
government health centres in Ndola, an urbanized city
o nt h eC o p p e r b e l tP r o v i n c eo fZ a m b i aw i t ha ne s t i -
mated population of 374,757 persons [5], representative
of many urban towns along the line of rail in Zambia.
At the time of the study, the Ndola District Health
Management Team (NDHMT) provided health care ser-
vices through 26 health centres. All the health centres
provided TB treatment and care (treatment centres), but
only six were able to perform Acid Fast Bacilli (AFB)
smear microscopy (diagnostic centres).
Sampling and sample size
The sampling frame comprised the names of all the
smear-positive TB patients, new and retreatment cases,
registered in the TB microscopy laboratory registers at
the six diagnostic centres between January 2006 and
July 2007, as a record of all smear-positive patients
undergoing treatment in the 26 treatment centres in
that period. Those that had received treatment from pri-
vate clinics or hospitals and children less than 18 years
of age were not included. A sample of 105 respondents
was randomly selected from the sampling frame. The
sample size was calculated using Epi Info 3.5.1 (Centers
for Disease Control and Prevention, Atlanta, GA, USA).
Based on pre-test results, we expected a frequency of
patient compliance and adherence to treatment of 50%
±10%, at a confidence interval of 95%, and non-response
level of 10%, and therefore estimated a sample size of
105 as sufficient.
Data collection, management and analysis
Initial contact with the selected respondents was made
through the TB focal persons at the health centres.
Trained research assistants from the Tropical Diseases
Research Centre (TDRC), interviewed consenting parti-
cipants using a structured questionnaire at their homes.
The questionnaire, bore questions to capture individual
data on socio-demographics, knowledge on TB, health
seeking behaviour, adherence to TB treatment, and
reported health centre care during treatment. Most of
the questions were closed ended. The questionnaire was
pre-tested before use and modifications incorporated in
the final version.
The collected data was entered in an MS Access data-
base using Epi Info™3.5.1 (Centers for Disease Control
and Prevention, Atlanta, GA, USA), with in-built consis-
tency and range checks. The database was converted to
SAS® 9.2 (SAS Institute Inc., Cary, NC, USA) for recod-
ing where necessary and final analyses. Fisher’se x a c t
Chi-squared test was used to examine associations of
factors. A p ≤ 0.05 was considered significant.
National Guidelines for management of TB
The management of TB patients in Zambia has been
standardised under guidelines provided by the NTLP
[6]. Except for the seriously ill and identified multidrug
resistant (MDR) cases, TB patients are treated on an
ambulatory basis. Patients are instructed to pick up
medication at TB treatment centres once or twice a
week during the intensive phase and once monthly dur-
ing the continuation phase. The national guidelines sti-
pulate that treatment during the intensive phase should
be under direct observation by a trained treatment sup-
porter - usually a relative, while the continuation phase
can be self-administered but with monthly supervision
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tant aspect of TB treatment management and is also
included in the guidelines to improve cure rates and
compliance. Further, as part of patient monitoring and
follow up, microscopy is to be repeated at 2, 5 and 8
months. To ensure and improve compliance to sputum
follow-up, it is the duty of treatment centres to (1)
ensure patients make follow-up visits and submit spu-
tum specimens as required (2) deliver sputum speci-
mens to the nearest diagnostic centre for microscopy
and (3) collect microscopy results from diagnostic cen-
tres and make available to patients for appropriate care.
Patients do not visit diagnostic centres themselves.
Conceptual framework
The following concepts were used to make analysis.
Respondent treatment adherence
Respondents that reported to have completed eight
months of taking medication without interruption, and
submitted sputum at least twice post diagnosis - one
time point being at eight months - were considered to
have adhered to the treatment programme.
Care giver treatment guidelines adherence
Caregivers that were reported by the respondents to
have enquired about patient’s TB history, provided
patient information (on TB disease and its treatment,
how to take medication, the requirement to submit fol-
low-up sputum during treatment and the importance of
submitting follow-up sputum), and gave the patient an
opportunity to ask questions, were considered to have
adhered to the TB treatment guidelines.
Respondent knowledge
Respondents that were able to name the correct mode
of TB transmission, at least two correct symptoms of
TB and knew the importance of treatment completion
and sputum submission were considered to be knowl-
edgeable about the disease and its treatment.
Health centre systems access
Health centre delivery systems were considered to be
adequate if respondents reported that: the distance to
the health centre was less than 30 minutes walk from
their home, he/she was commenced on TB treatment
not more than 5 days post laboratory diagnosis, and he/
she used the same clinic for follow-up treatment and
follow-up sputum submission.
Ethical consideration
Approval for the study protocol was obtained from the
Ethics Committee at TDRC. Approval and support were
also obtained from the Director of the NDHMT. Con-
senting respondents were asked to sign an informed
consent following an explanation of the study. Inter-
viewers were not part of the health care system. Respon-
dents were assured of anonymity and confidentiality.
Results
Respondent characteristics and health seeking attitudes
Basic Respondent socio-demographic characteristics
are shown in Table 1. Other results showed that 68%
of respondents waited for one month or more since
the onset of symptoms before going to the health cen-
tre. When asked why they waited that long, most of
the respondents (76%) thought the symptoms will go
Table 1 Socio-demographic characteristics of the
respondents (N = 105)
n%
Sex
Female 50 48
Male 55 52
Age (years)
15 - 24 13 12
25 - 34 33 31
35 - 44 29 28
45 - 54 16 15
55 - 64 7 7
>6 5 7 7
Marital Status
Married/Cohabiting 58 55
Single 23 22
Divorced/Separated 11 11
Widowed 13 12
Education
None 8 8
Primary 44 42
Secondary 50 48
Tertiary 3 3
Employment
Formal 18 17
Informal 44 42
Housewife 13 12
Dependent 15 14
Unemployed 15 14
Distance to clinic
5-10 minutes 41 39
20-30 minutes 43 41
45 minutes 9 9
1 hour 10 10
Too far to walk, need to get bus 2 2
Previous episode of TB
Yes 23 22
No 82 78
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with symptoms prior to visiting the health centre was
self-treatment (64%). Most of the respondents (98%)
only presented at the health centre when they were
feeling very sick. When asked if they suspected that
they had TB, 30 respondents (29%) responded in the
affirmative. However, 73% of these respondents still
waited for at least one month before going to the
health centre.
Respondent treatment adherence
When respondents were asked if they had stopped tak-
ing their medication at some point during treatment,
22% said yes, and the most common reason for stopping
was that the respondent felt better (55%). Among
respondents that were asked the number of times they
submitted sputum after initiation of treatment, 32%
reported submitting sputum at three time points, 25% at
two time points, whilst 43% submitted sputum only
once post treatment initiation. Two thirds (67%) of the
respondents reported submitting sputum at the end of
treatment, (eight months). Adherence to treatment of
respondents is shown in Table 2 (A).
Care giver treatment guidelines adherence
The majority of respondents (84%) confirmed that they
were asked if they had suffered from TB previously
before commencement of TB treatment. To the ques-
tions enquiring whether the health-worker explained
how to take the medication and whether the instruc-
tions were clear, nearly all responded favourably. When
asked if the health worker informed them at the initia-
tion of treatment that they would have to submit more
sputum samples during treatment, 53% said yes; all of
whom reported that the health centre staff explained to
them the importance of submitting follow-up sputum
specimens. Forty-nine (47%) respondents reported that
they were given an opportunity to ask questions for
clarifications. Table 2 (B) shows performance of care-
givers’ adherence to treatment guidelines.
Respondent knowledge and awareness of TB
When asked to name some symptoms of TB, a signifi-
cant proportion of the respondents (78%) was able to
mention at least two symptoms, with cough being the
most identified symptom (89%). A considerable number
(69%) of the respondents correctly knew the mode of
Table 2 Distribution of respondent and caregiver adherence and health systems access in Ndola, Zambia (N = 105)
n%
A. Respondent adherence to treatment programme
Respondents that complied and adhered to treatment programme 45 43
1. Respondents that completed medication without stopping at any point 81 77
2. Respondents that submitted sputum as required 50 48
B. Caregiver adherence to treatment guideline
Respondents whose caregivers adhered to treatment guidelines 26 25
1. Respondents whose caregivers enquired about their TB history 88 84
2. Respondents whose caregivers educated them on:
the disease and its treatment 103 98
how to take medication 105 100
requirement of submitting follow-up sputum 56 53
the importance of follow-up sputum submission 57 54
3. Respondents who were given an opportunity to ask questions 49 47
C. Respondents’ knowledge on the disease
Respondents that demonstrated knowledge on the disease and its treatment 30 29
1. Respondents that gave the correct mode of TB transmission 73 70
2. Respondents that gave at least two correct symptoms of TB 82 78
3. Respondents that knew the importance of treatment completion 94 90
4. Respondents that knew the importance of follow-up sputum submission 57 54
D. Health centre systems access
Respondents that reported adequate healthcare systems access 84 80
1. Respondents who reported the distance to the health centre as being too far 84 80
2. Respondents who reported commencing treatment within a week of diagnosis 105 100
3. Respondents who reported using the same clinic for treatment and sputum submission 77 73
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the same utensils. Knowledge of the importance of com-
pleting medication for eight months was high (89%) but
knowledge for the importance of submitting follow-up
sputum was lower (55%). Ninety-one percent of the
respondents reported that they knew they were cured of
their last TB episode, but when asked how they knew
they were cured, reasons ranged from feeling better
(80%), the fact that they took medication for eight
months (15%), to that laboratory results were negative
(4%). Table 2 (C) shows performance of respondents
with regards to knowledge and awareness of TB. Most
respondents (71%) did not suspect that they had TB
despite the large number (85%) naming cough as one of
the symptoms they experienced.
Healthcare systems access
TB treatment centres appeared relatively close to the
respondents’ homes: 80% lived within 30 minutes walk,
18% lived within an hour’s walk and 2% said it was too
far to walk and needed to take a bus. Respondents were
also asked how long after being diagnosed with TB it
took before starting medication; all the respondents
reported that they were started on treatment within one
week of diagnosis, with 86% starting within two days.
When respondents were asked if they had used the
same clinic for their follow-up visits and drug collection
throughout treatment, affirmative responses were 87%.
Respondents were further asked if they had submitted
their follow-up sputum samples to the same clinic they
went for reviews and collected drugs from, and 73% said
yes. Table 2 (D) shows performance of health centres
with regards to access as reported by the respondents.
Factors significantly associated with respondent adherence
The results showed that, using our conceptual frame-
work, respondents’ adherence to treatment was not only
significantly associated with respondent’sk n o w l e d g e
about the disease and its treatment (p < 0.0001), but
also with reported caregivers’ adherence to treatment
guidelines (p = 0.0027) and reported adequate health-
care systems access (p < 0.0001) (Table 3).
Further analyses showed that caregivers explaining the
importance and schedule of follow-up sputum submis-
sion was significantly associated with respondents’
adherence to sputum submission as required (p <
0.0001), but not with respondents’ completing medica-
tion for eight months (p = 0.0562).
Discussion
The success of a national TB program is multi-faceted
and complex. Community awareness; patients’ adher-
ence to treatment; patient access to quality of care
through competent healthcare staff who are able to pro-
vide quality of care through prompt diagnosis and refer-
ral, prescription of correct treatment regimens and
treatment follow-up; and accessible TB services, are
important components of a successful TB program.
Consequently, it is important that people in commu-
nities are aware and able to suspect TB in persons who
show signs and symptoms suggestive of the disease,
such as prolonged cough, persistent fevers, and weight
loss. Maybe not surprising, as previous TB patients our
respondents showed a good level of knowledge on the
symptoms and modes of transmission of TB, attributable
to caregiver education during treatment. However, our
study revealed vast differences in knowledge regarding
the importance of treatment completion compared to
knowledge of the importance of follow-up sputum sub-
mission; whereas, nearly 90% knew the importance of
treatment completion, only 57% knew the importance of
the latter, reflective of the low importance given to the
relevance of education on this issue. Similarly, other stu-
dies have shown that most TB patients know the impor-
tance of treatment completion [7-9]. According to our
conceptual framework, overall knowledge of the disease
was low, mainly due to the low knowledge gap in the
role of sputum microscopy in TB treatment by the
respondents.
Despite the high knowledge levels of TB symptoms
shown in our study, most respondents not only,
reported not to have suspected they had TB, but also
reported that they delayed seeking care (even when they
suspected they had TB). Whereas it is possible that
respondents were truly unaware of TB symptoms prior
to TB treatment, several other studies have shown that
there are various reasons why patients delay seeking
care at a health centres. Loss of income, health centre
systems or staff attitudes, stigma of the HIV association,
severity of disease, lifestyle, for example, alcohol abuse,
are among the many explanations [9-13]. The most
common reasons in our study, ‘I was thinking the symp-
toms will go away’ or ‘I did not think it was serious’ also
appear to be common in different settings [8,12]. This
may be reflective of the commonly practiced self-treat-
ment, which may ameliorate initial symptoms thus
temporarily masking the severity of disease and conse-
quently ‘buy them time’ to continue with their daily
income generating endeavours. Only 17% of our study
population were in formal employment suggesting that
for most respondents an income was dependent on their
daily efforts and therefore may not afford the time at
the health centre. Further, the period of the study, were
the early days of scaling up of free antiretroviral therapy
in Zambia and so people may still have been feeling
helpless against HIV infection.
Our results showed that only 47% of respondents
reported to have submitted follow-up sputum at least
twice post diagnosis and that 67% reported submitting
follow-up sputum at the end of treatment. These results
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tion at the end of the patient’s treatment is a much
stronger indicator of treatment success than ‘treatment
completion. Further, data in one of our studies in this
population, has shown that among subjects who experi-
enced another episode of TB within one year of complet-
ing treatment, there were more who harboured the same
M. tuberculosis strain as that of the previous episode
(relapses/treatment failures) than those that had a differ-
ent strain (re-infection) (unpublished data). Furthermore,
our study showed a high proportion of respondents tak-
ing of drugs for the complete period of treatment (89%)
with a notable proportion (22%) reporting stopping med-
ication at some point during treatment. Over half (55%)
cited that they stopped because they were feeling better,
similar to many other studies [14,8,15].
The role of the health worker on patient compliance
has been described many times [16-18]. Patient counsel-
ling and good communication [19,20] can improve
patient compliance. Our study showed high levels of
patient satisfaction when it came to health provider
explanation regarding medication. However, we did not
see the same positive response with regards to health
provider explanation on the role of follow-up sputum
submission. Only about half of the respondents reported
that they were informed about the requirement (53%)
and importance (54%) of submitting follow-up sputum.
In fact, these two parameters were shown to be signifi-
cantly associated with respondent adherence (p < 0.0001
for both). A study in Egypt demonstrated that adherence
to recommended sputum smear microscopy schedule
was significantly associated with treatment success [21].
Our study also showed that respondent adherence to
treatment was significantly associated with respondent’s
knowledge about the disease and its treatment (p <
0.0001) in contrast to other studies [22,8].
Moreover, caregivers’ communication skills fell short
on account of dialogue, giving the patient a chance to
ask questions, an important aspect in patient manage-
ment that ensures patient understanding of disease and
treatment. The effects of non-dialogue counselling were
demonstrated in a study in Madagascar where reported
lack of opportunity to ask questions by patient was sig-
nificantly associated with non-adherence [16].
Other features of the health system, like distance, con-
venience of TB services (microscopy, antiretroviral treat-
ment services), how long it takes to see the clinician,
prompt diagnosis and referral of TB patients presenting
with TB-related symptoms at primary health care facil-
ities, may have an effect on patient access to healthcare.
Distance to the health centre for this population was
not an issue. Delays in the commencement of treatment
have been documented in some settings [23], our study,
however, showed that all the respondents were given
medication within one week of diagnosis, with 84%
commencing treatment within two days post laboratory
diagnosis. The NTLP in Zambia has given full responsi-
bility of sputum transportation plus obtaining and com-
municating results for each patient, to the treatment
centres. This not only reduces on the number of
patients, who remain undiagnosed following initial
health centre visit, but also removes the inconvenience
and added travel costs from the patients. The majority
of our respondents reported that they used the same
treatment centre for sputum submission. Our results
indicate that facility-service related factors may not be
the main issue in patients’ access to TB care in Ndola,
unlike the study from KwaZulu-Natal where systems
failure was reported as contributing to the ineffective-
ness of the National Tuberculosis Program [24].
Admittedly, because this study asked questions about
past events, participants’ recall may have biased our
Table 3 Respondent adherence associations to Caregiver adherence, Respondent knowledge and Health system
accessibility (N = 105)
Respondent adherence to treatment programme
Characteristics Adhered Did not adhere *P value
A. Caregiver adherence to treatment guidelines
Did not adhere to guidelines 27 52
Adhered to guidelines 18 8 0.0027
B. Respondents’ knowledge on TB
Not knowledgeable 20 55
Knowledgeable 25 5 < 0.0001
C. Health centre systems access
Not good/not efficient 0 21
Good/efficient 45 39 < 0.0001
*P values are based on Fisher’s exact chi square test.
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to ensure complete confidentiality, we were not able to
go back to the patient’s data files to verify the self-
reported data. Nevertheless, the implied cure rate for
this sample population is comparable to the average
cure rate data for the same period from Ndola. Another
limitation for this study is that we did not establish
from the respondents how long it took for laboratory
results to be available for diagnosis, a factor that could
well contribute to delay in TB patient care. However,
enquiries from TB focal persons indicated a turnaround
time for lab results ranging from the same day to a
week. Further, our study did not include all components
of TB treatment and care in the National Guidelines
and consequently, other components that contribute to
this package have not been discussed. Lastly, it is well
known that respondents usually consider the interviewer
to represent authority or the healthcare system and
therefore tend to bias their answers in the way they
expect they should to please the interviewer. Conse-
quently, although the study made efforts to use
researchers from outside the respondents’ healthcare
system, it is difficult to completely remove this percep-
tion in communities.
Conclusions
In conclusion, TB treatment systems appear to be well
in place in NDHMT. However, taken together, these
results suggest that closer monitoring systems on guide-
lines adherence at health centres may need strengthen-
ing and more patient counselling on treatment of
disease and importance of sputum submission may
improve cure rates.
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